JenPlateau said:Insurance update relevant to cost and coverage: I just got my prior auth approved through Cigna after 4 attempts.
Telehealth prescriber review for cost and coverage: I've used 3 different telehealth platforms to get my GLP-1 prescription. Comparison:
| Feature | Platform A | Platform B | Platform C |
|---|---|---|---|
| Initial Consult | $58 | $98 | $0 |
| Monthly Follow-up | $48 | Included | $58 |
| Prescription Speed | Same day | 24-48 hours | Same day |
| Lab Monitoring | Required | Optional | Required |
I settled on the one that required labs — it shows they care about safety, not just prescribing volume.
raj_cambridge said:Dr.LipidDallas said: ...regarding the discontinuation data for cost and coverage...
Saving this. It is the first explanation that did not require me to already understand it. Sending this to two other people who asked me the same thing last week.
JenPlateau said:Insurance update relevant to cost and coverage: I just got my prior auth approved through Cigna after 4 attempts.
My insurance denied my PA related to cost and coverage. Has anyone successfully appealed? I'm considering going compounded instead.
Sigma-Aldrich — Research-Grade Standards
Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.
Shop Reference StandardsSarahChen_PharmD said:Denied on prior authorisation twice, approved on the third attempt after a peer-to-peer, and the only thing that changed was who was doing the…
SarahChen_PharmD said:...compounded vs brand cost and coverage...
This debate comes up weekly and I think both sides have valid points:
Pro-brand: FDA-approved, manufacturing standards guaranteed, clinical trial data directly applicable
Pro-compounded: 10x cost savings, same active molecule, independent testing available, accessibility
My position: if you can afford brand or have insurance coverage, that's the gold standard. If not, properly tested compounded from a 503B pharmacy is a reasonable alternative. Neither side should shame the other.
Moderator note: the sourcing question belongs in the vendor section and has been split out. Report rather than reply if it drifts again.